This page lists the SEC filings reported by WEXFORD CAPITAL LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2014-11-20 | WEXFORD CAPITAL LP | Diamondback Energy, Inc. | 5,498,795 | 9.7% | EDGAR |
| SC 13D/A | 2014-09-25 | WEXFORD CAPITAL LP | Diamondback Energy, Inc. | 6,779,109 | 12.0% | EDGAR |
| SC 13D/A | 2014-09-09 | WEXFORD CAPITAL LP | NEPHROS INC | 26,496,616 | 66.6% | EDGAR |
| SC 13G/A | 2014-07-03 | WEXFORD CAPITAL LP | Diamondback Energy, Inc. | 8,134,376 | 16.0% | EDGAR |
| SC 13G/A | 2014-05-20 | WEXFORD CAPITAL LP | CACHE INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2014-04-09 | WEXFORD CAPITAL LP | NEPHROS INC | 26,496,616 | 66.7% | EDGAR |
| SC 13G | 2014-03-28 | WEXFORD CAPITAL LP | FAMOUS DAVES OF AMERICA INC | 8,080 | 0.1% | EDGAR |
| SC 13D/A | 2014-03-26 | WEXFORD CAPITAL LP | Diamondback Energy, Inc. | 9,310,128 | 18.4% | EDGAR |
| SC 13D/A | 2014-03-04 | WEXFORD CAPITAL LP | Diamondback Energy, Inc. | 9,847,175 | 19.5% | EDGAR |
| SC 13G/A | 2014-02-14 | WEXFORD CAPITAL LP | Arno Therapeutics, Inc | 373,760 | 1.8% | EDGAR |
| SC 13G/A | 2014-02-14 | WEXFORD CAPITAL LP | REPROS THERAPEUTICS INC. | 630 | 2.5% | EDGAR |
| SC 13G/A | 2014-02-14 | WEXFORD CAPITAL LP | Revett Minerals Inc. | 328,189 | 1.0% | EDGAR |
| SC 13G/A | 2014-02-14 | WEXFORD CAPITAL LP | Integrated Drilling Equipment Holdings Corp | 208,875 | 2.4% | EDGAR |
| SC 13G/A | 2014-02-14 | WEXFORD CAPITAL LP | ONCOVISTA INNOVATIVE THERAPIES, INC | 1,714,284 | 7.9% | EDGAR |
| SC 13G/A | 2014-02-14 | WEXFORD CAPITAL LP | RLJ ENTERTAINMENT, INC. | 1,530,000 | 11.2% | EDGAR |
| SC 13G | 2014-01-08 | WEXFORD CAPITAL LP | CACHE INC | 1,027,882 | 4.8% | EDGAR |
| SC 13D/A | 2013-12-05 | WEXFORD CAPITAL LP | CAPRICOR THERAPEUTICS, INC. | 38,202 | 0.3% | EDGAR |
| SC 13D/A | 2013-11-18 | WEXFORD CAPITAL LP | Diamondback Energy, Inc. | 10,105,481 | 21.5% | EDGAR |
| SC 13D/A | 2013-11-18 | WEXFORD CAPITAL LP | NEPHROS INC | 18,310,827 | 61.8% | EDGAR |
| SC 13G | 2013-10-17 | WEXFORD CAPITAL LP | Arno Therapeutics, Inc | 3,238,080 | 8.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.